|Dataset||DrugBank Drug Targets|
|Description||A member of the class of ureas that is urea in which one of the hydrogens is replaced by a hydroxy group. An antineoplastic used in the treatment of chronic myeloid leukaemia as well as for sickle-cell disease. (Chemical Entities of Biological Interest Ontology, CHEBI_44423)|
|Downloads & Tools|
1 interacting proteins for the Hydroxyurea drug from the curated DrugBank Drug Targets dataset.
|RRM1||ribonucleotide reductase M1|